What it isCalcineurin inhibitor blocking T-cell activation; transplant rejection, psoriasis, and uveitis.
Why this oneIt provides rapid, potent immunosuppression without myelosuppression and works quickly in severe psoriasis.
What limits itNephrotoxicity and hypertension require creatinine and blood-pressure monitoring. A narrow index plus CYP3A4 and P-gp interactions makes levels essential.
BOXED WARNING Only clinicians experienced in immunosuppression/organ-transplant management should prescribe; increases susceptibility to infection and to lymphoma/other neoplasia. Neoral and Sandimmune are not bioequivalent and are not interchangeable without physician supervision; monitor blood concentrations.
FDA dosing
Population
Start
Target
Max
Organ transplant (kidney/liver/heart) — prophylaxis of rejection
Adults
kidney 9, liver 8, heart 7 mg/kg/day BID divided
titrate to target blood trough concentration
Rheumatoid arthritis
Adults
2.5 mg/kg/day BID divided
4 mg/kg/day
Psoriasis
Adults
2.5 mg/kg/day BID divided
4 mg/kg/day
Titration RA: increase 0.5–0.75 mg/kg/day after 8 wk, again after 12 wk; psoriasis: increase ~0.5 mg/kg/day at 2-wk intervals after initial 4 wk
Renal Transplant: monitor renal function, reduce dose if indicated (nephrotoxic). RA/psoriasis: contraindicated in patients with impaired/abnormal renal function
Hepatic Reduce dose in severe liver impairment (clearance may be significantly reduced)
Instructions
Always give in two divided doses (BID) on a consistent schedule relative to meals
Avoid grapefruit and grapefruit juice
Oral solution: dilute with room-temperature orange or apple juice in a glass container and drink at once; do not let stand
Contraindications
Rheumatoid arthritis or psoriasis patients with abnormal renal function, uncontrolled hypertension, or malignancy
Psoriasis: concomitant PUVA/UVB, methotrexate or other immunosuppressives, coal tar, or radiation therapy
Cautions
Nephrotoxicity — monitor renal function
Hypertension
Increased risk of infection and of lymphoma/malignancy
Not bioequivalent to Sandimmune
Adverse reactions
Renal dysfunction
Hypertension
Hirsutism/hypertrichosis
Tremor
Gum hyperplasia
Headache
GI disturbances (nausea, diarrhea)
Pregnancy No identified drug-associated risk of major birth defects/miscarriage; increased hypertension, preeclampsia, preterm birth, and low birth weight
Lactation Undefined
⚠ BOXED WARNINGS
Administer under specialist supervision
Increased susceptibility to infection and lymphoma